Autoinjector

An autoinjector is a prefilled syringe or cartridge wrapped in a mechanism that automates the two steps people find hardest: pushing a needle through skin and emptying a viscous solution at a controlled rate. A compressed spring, or in some designs a gas cell, drives insertion to a fixed depth and then advances the plunger, and a shield locks over the needle on withdrawal. Almost all are single-use and deliver one preset amount, which is the structural difference from a pen injector, where the user selects from a dial and one cartridge serves several administrations.

The category spans epinephrine for anaphylaxis, monoclonal antibodies such as adalimumab, and the weekly incretin agonists, with dulaglutide and semaglutide both marketed in pen-style devices where the needle is never visible. Regulators treat these as combination products, so approval requires human-factors validation with untrained participants. The failure modes that literature documents are mundane: removing the wrong cap, lifting the device off the skin early, and misreading the end-of-dose signal.

The tradeoff is control against flexibility. A fixed presentation removes the arithmetic and the needle handling, which is why technique tends to be better than with a vial and syringe, but it forecloses adjustment and its spring is tuned to one formulation viscosity. Concentrated or cold solutions inject slowly, which is why hold times are specified.

The common error is reading the presence of an autoinjector as evidence of an approved, quality-controlled product. Empty housings and cartridges are commodity hardware, and grey-market material is sometimes presented in formats borrowed from approved drugs, which says nothing about identity, sterility or content. A shorter stated injection time is likewise a specification of the mechanism and the fluid, not a measure of absorption.